CY1121731T1 - Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα - Google Patents
Βιοαποικοδομησιμο οφθαλμικο εμφυτευμαInfo
- Publication number
- CY1121731T1 CY1121731T1 CY20191100615T CY191100615T CY1121731T1 CY 1121731 T1 CY1121731 T1 CY 1121731T1 CY 20191100615 T CY20191100615 T CY 20191100615T CY 191100615 T CY191100615 T CY 191100615T CY 1121731 T1 CY1121731 T1 CY 1121731T1
- Authority
- CY
- Cyprus
- Prior art keywords
- eye implant
- implants
- biodegradable
- biodegradable eye
- ocular
- Prior art date
Links
- 239000007943 implant Substances 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Η εφεύρεση παρέχει βιοαποικοδομήσιμα εμφυτεύματα καταλλήλου μεγέθους για εμφύτευση εντός μίας οφθαλμικής περιοχής και μεθόδους για την αγωγή ιατρικών καταστάσεων του οφθαλμού. Τα εμφυτεύματα σχηματίζονται από ένα μίγμα PLGA με υδρόφιλο άκρο και υδρόφοβο άκρο και χορηγούν δραστικούς παράγοντες εντός μίας οφθαλμικής περιοχής χωρίς υψηλή απότομη αποδέσμευση.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/340,237 US20040137059A1 (en) | 2003-01-09 | 2003-01-09 | Biodegradable ocular implant |
EP08002892.1A EP1917957B1 (en) | 2003-01-09 | 2004-01-07 | Biodegradable ocular implant |
PCT/US2004/000351 WO2004062649A2 (en) | 2003-01-09 | 2004-01-07 | Biodegradable ocular implant |
EP04700611A EP1581193B1 (en) | 2003-01-09 | 2004-01-07 | Biodegradable ocular implant |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1121731T1 true CY1121731T1 (el) | 2020-07-31 |
Family
ID=32711277
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100057T CY1118431T1 (el) | 2003-01-09 | 2017-01-17 | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα |
CY20181100250T CY1120147T1 (el) | 2003-01-09 | 2018-02-28 | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα |
CY20191100615T CY1121731T1 (el) | 2003-01-09 | 2019-06-13 | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα |
CY20191100865T CY1121912T1 (el) | 2003-01-09 | 2019-08-13 | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100057T CY1118431T1 (el) | 2003-01-09 | 2017-01-17 | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα |
CY20181100250T CY1120147T1 (el) | 2003-01-09 | 2018-02-28 | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20191100865T CY1121912T1 (el) | 2003-01-09 | 2019-08-13 | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα |
Country Status (21)
Country | Link |
---|---|
US (1) | US20040137059A1 (el) |
EP (6) | EP1917957B1 (el) |
JP (1) | JP4223040B2 (el) |
KR (1) | KR20050099008A (el) |
CN (2) | CN100364514C (el) |
AT (1) | ATE555779T1 (el) |
AU (1) | AU2004204744B2 (el) |
BR (2) | BRPI0406692A (el) |
CA (1) | CA2512315C (el) |
CY (4) | CY1118431T1 (el) |
DK (5) | DK3305284T3 (el) |
ES (5) | ES2384875T3 (el) |
FR (1) | FR12C0067I1 (el) |
HK (1) | HK1084021A1 (el) |
HU (4) | HUE044965T2 (el) |
MX (1) | MXPA05007342A (el) |
NZ (1) | NZ540451A (el) |
PT (4) | PT2799064T (el) |
SI (3) | SI3305284T1 (el) |
TR (2) | TR201908857T4 (el) |
WO (1) | WO2004062649A2 (el) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US20060280774A1 (en) * | 1995-06-02 | 2006-12-14 | Allergan, Inc. | Compositions and methods for treating glaucoma |
US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
AU3649502A (en) | 2000-11-29 | 2002-06-11 | Oculex Pharm Inc | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US20050048099A1 (en) * | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
US8246974B2 (en) | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
ATE476960T1 (de) | 2003-05-02 | 2010-08-15 | Surmodics Inc | System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges |
US7060723B2 (en) | 2003-08-29 | 2006-06-13 | Allergan, Inc. | Treating neurological disorders using selective antagonists of persistent sodium current |
US7125908B2 (en) * | 2003-08-29 | 2006-10-24 | Allergan, Inc. | Treating pain using selective antagonists of persistent sodium current |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
CA2553381C (en) | 2004-01-20 | 2011-03-22 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
US20050244469A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
US8425929B2 (en) * | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US20050244466A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Photodynamic therapy in conjunction with intraocular implants |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
US8685435B2 (en) * | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US8147865B2 (en) | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
AU2005314426A1 (en) * | 2004-12-10 | 2006-06-15 | Talima Therapeutics, Inc. | Compositions and methods for treating conditions of the nail unit |
US20060275230A1 (en) | 2004-12-10 | 2006-12-07 | Frank Kochinke | Compositions and methods for treating conditions of the nail unit |
AU2011236024B2 (en) * | 2005-03-01 | 2013-05-23 | Allergan, Inc. | Microimplants for ocular administration |
US20060204548A1 (en) * | 2005-03-01 | 2006-09-14 | Allergan, Inc. | Microimplants for ocular administration |
US20090082321A1 (en) * | 2007-09-21 | 2009-03-26 | Allergan, Inc. | Steroid containing drug delivery systems |
US20070178138A1 (en) * | 2006-02-01 | 2007-08-02 | Allergan, Inc. | Biodegradable non-opthalmic implants and related methods |
US20070260203A1 (en) * | 2006-05-04 | 2007-11-08 | Allergan, Inc. | Vasoactive agent intraocular implant |
US8802128B2 (en) | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
EP1917971A1 (en) | 2006-10-27 | 2008-05-07 | Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) | Substained release formulations comprising very low molecular weight polymers |
US8969415B2 (en) * | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
US8536190B2 (en) * | 2007-01-30 | 2013-09-17 | Allergan, Inc. | Treating unwanted ocular conditions using an ascomycin macrolactam |
CN101678038A (zh) * | 2007-03-14 | 2010-03-24 | 华盛顿大学 | 用于眼内药物递送的装置和方法 |
US20080317805A1 (en) * | 2007-06-19 | 2008-12-25 | Mckay William F | Locally administrated low doses of corticosteroids |
MX2010002616A (es) * | 2007-09-07 | 2010-08-04 | Qlt Plug Delivery Inc | Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos. |
US8353862B2 (en) | 2007-11-02 | 2013-01-15 | Allergan, Inc. | Drug delivery systems and methods |
US9125917B2 (en) * | 2008-04-18 | 2015-09-08 | Warsaw Orthopedic, Inc. | Fluocinolone formulations in a biodegradable polymer carrier |
US8524267B2 (en) * | 2008-04-18 | 2013-09-03 | Warsaw Orthopedic, Inc. | Dexamethasone formulations in a biodegradable material |
CN102026599A (zh) | 2008-05-12 | 2011-04-20 | 犹他大学研究基金会 | 眼内药物递送装置及相关方法 |
US10588855B2 (en) | 2008-05-12 | 2020-03-17 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9877973B2 (en) | 2008-05-12 | 2018-01-30 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US10064819B2 (en) | 2008-05-12 | 2018-09-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9095404B2 (en) | 2008-05-12 | 2015-08-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
WO2009143288A1 (en) * | 2008-05-20 | 2009-11-26 | Yale University | Biodegradable sustained-release polymeric microparticulates comprising a hydrophobic drug and determined for ophthalmic use |
US20110206773A1 (en) * | 2008-05-20 | 2011-08-25 | Yale University | Sustained delivery of drugs from biodegradable polymeric microparticles |
CN101612111B (zh) * | 2008-06-24 | 2011-11-23 | 上海医药工业研究院 | 醋酸诺美孕酮或其类似物的缓释微球及其制备方法和用途 |
US10842669B2 (en) | 2008-11-13 | 2020-11-24 | Gholam A. Peyman | Ophthalmic drug delivery method |
US10272035B2 (en) | 2008-11-13 | 2019-04-30 | Gholam A. Peyman | Ophthalmic drug delivery method |
US20110125090A1 (en) * | 2008-11-13 | 2011-05-26 | Peyman Gholam A | Ophthalmic drug delivery system and method |
US20100204325A1 (en) * | 2009-02-11 | 2010-08-12 | Allergan, Inc. | Valproic acid drug delivery systems and intraocular therapeutic uses thereof |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US20100303757A1 (en) | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Chronic Neurogenic Inflammation Using Interleukin Retargeted Endopepidases |
US20100303788A1 (en) * | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases |
US20100303783A1 (en) * | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases |
US20100303794A1 (en) | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases |
WO2011020052A1 (en) | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using opioid retargeted endpeptidases |
CA2771297A1 (en) | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using neurotrophin retargeted endopeptidases |
WO2011020056A2 (en) | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using galanin retargeted endpeptidases |
KR20140015129A (ko) | 2009-08-14 | 2014-02-06 | 알러간, 인코포레이티드 | 성장 인자 재표적화된 엔도펩티다아제를 사용하여 암을 치료하는 방법 |
CN102574899A (zh) | 2009-08-14 | 2012-07-11 | 阿勒根公司 | 使用胰高血糖素样激素再靶向内肽酶治疗癌症的方法 |
WO2011020114A2 (en) | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using tachykinin retargeted endopeptidases |
EP2534137B1 (en) | 2010-02-08 | 2015-09-16 | Allergan, Inc. | Pyridazine derivatives useful as cannabinoid-2 agonists |
US20130030055A1 (en) | 2010-03-24 | 2013-01-31 | Allergan, Inc. | Compositions and methods for treating hair loss, hair thinning, and hair color loss |
US8349005B2 (en) | 2011-01-03 | 2013-01-08 | Masatoshi Murata | Method for burying implant to choroid |
WO2012112432A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Methods of inhibiting aberrant blood vessel formation using opioid retargeted endopeptidases |
US20120207742A1 (en) | 2011-02-14 | 2012-08-16 | Allergan, Inc. | Treatments Using PSMA Ligand Endopeptidases |
WO2012112426A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Arginine vasopressin retargeted clostridial endopeptidases for use in treating benign prostatic hyperplasia |
WO2012112434A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Inhibiting aberrant blood vessel formation using retargeted endopeptidases |
WO2012112422A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Inhibiting aberrant blood vessel formation using growth factor retargeted endopeptidases |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
EP2855030B1 (en) | 2012-06-01 | 2019-08-21 | SurModics, Inc. | Apparatus and method for coating balloon catheters |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
WO2014066644A1 (en) | 2012-10-26 | 2014-05-01 | Allergan, Inc. | Ketorolac-containing sustained release drug delivery systems |
CA2897197C (en) | 2013-01-15 | 2022-06-07 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal system drug delivery device |
JP2016514024A (ja) | 2013-03-14 | 2016-05-19 | ハラックス,インコーポレイテッド | 爪部の感染症、疾患または障害の治療方法 |
KR102307281B1 (ko) * | 2013-10-31 | 2021-09-29 | 알레간 인코포레이티드 | 프로스타마이드-함유 안구내 삽입물 및 그것의 사용 방법 |
CA2939651A1 (en) * | 2014-02-26 | 2015-09-03 | Allergan, Inc. | Intraocular implant delivery apparatus and methods of use thereof |
JP6655610B2 (ja) | 2014-05-29 | 2020-02-26 | グローコス コーポレーション | 制御された薬物送達機能を備えるインプラント及びそれを使用する方法 |
US10363163B2 (en) | 2014-09-11 | 2019-07-30 | EyePoint Pharmaceuticals, Inc. | Injector apparatus |
FR3028410A1 (fr) | 2014-11-18 | 2016-05-20 | Pierre Coulon | Implant capsulaire multifonctionnel |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
USD851755S1 (en) | 2015-10-22 | 2019-06-18 | Eyepoint Pharmaceuticals Us, Inc. | Ocular inserter |
WO2017091404A1 (en) | 2015-11-23 | 2017-06-01 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal system for drug delivery |
JP7003110B2 (ja) | 2016-04-20 | 2022-01-20 | ドーズ メディカル コーポレーション | 生体吸収性眼球薬物送達デバイス |
JP7054211B2 (ja) | 2016-05-20 | 2022-04-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイト | 涙腺ドラッグ送給デバイス |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4322323A (en) * | 1980-12-01 | 1982-03-30 | Alza Corporation | Erodible device comprising surfactant for modifying the rate of erosion of the device |
DE3168032D1 (en) * | 1980-11-10 | 1985-02-14 | Alza Corp | Erodible polymer containing erosion rate modifier |
US4883457A (en) * | 1983-08-18 | 1989-11-28 | Drug Delivery Systems Inc. | Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same |
US6309669B1 (en) * | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
US6217911B1 (en) * | 1995-05-22 | 2001-04-17 | The United States Of America As Represented By The Secretary Of The Army | sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres |
US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
JPS63291419A (ja) * | 1987-05-24 | 1988-11-29 | Tatsumo Kk | 加熱処理装置 |
US4853224A (en) * | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
US4997652A (en) * | 1987-12-22 | 1991-03-05 | Visionex | Biodegradable ocular implants |
US5164188A (en) * | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
KR0185215B1 (ko) * | 1990-11-30 | 1999-05-01 | 요시다 쇼오지 | 서방성 안구삽입용 약제 |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
PT654256E (pt) * | 1993-02-26 | 2000-12-29 | Santen Pharmaceutical Co Ltd | Rolha de esclerotica biodegradavel |
US5707643A (en) * | 1993-02-26 | 1998-01-13 | Santen Pharmaceutical Co., Ltd. | Biodegradable scleral plug |
US5443505A (en) * | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US6369116B1 (en) | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
WO1997026869A1 (en) * | 1996-01-24 | 1997-07-31 | United States Government Represented By The Secretary Of The Army | Novel 'burst-free' sustained release poly-(lactide/glycolide) microspheres |
EP0992244A4 (en) * | 1997-07-02 | 2001-01-17 | Santen Pharmaceutical Co Ltd | SCLERAL PLUGS OF POLYLACTIC ACID |
US6306426B1 (en) * | 1997-08-11 | 2001-10-23 | Allergan Sales, Inc. | Implant device with a retinoid for improved biocompatibility |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
AU3649502A (en) * | 2000-11-29 | 2002-06-11 | Oculex Pharm Inc | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
-
2003
- 2003-01-09 US US10/340,237 patent/US20040137059A1/en not_active Abandoned
-
2004
- 2004-01-07 SI SI200432476T patent/SI3305284T1/sl unknown
- 2004-01-07 CN CNB2004800020739A patent/CN100364514C/zh not_active Expired - Lifetime
- 2004-01-07 MX MXPA05007342A patent/MXPA05007342A/es active IP Right Grant
- 2004-01-07 ES ES04700611T patent/ES2384875T3/es not_active Expired - Lifetime
- 2004-01-07 HU HUE16198417 patent/HUE044965T2/hu unknown
- 2004-01-07 EP EP08002892.1A patent/EP1917957B1/en not_active Expired - Lifetime
- 2004-01-07 PT PT141655936T patent/PT2799064T/pt unknown
- 2004-01-07 DK DK17188114.7T patent/DK3305284T3/da active
- 2004-01-07 KR KR1020057012697A patent/KR20050099008A/ko not_active Application Discontinuation
- 2004-01-07 ES ES17188114T patent/ES2742152T3/es not_active Expired - Lifetime
- 2004-01-07 ES ES08002892.1T patent/ES2613028T3/es not_active Expired - Lifetime
- 2004-01-07 HU HUE14165593A patent/HUE036209T2/hu unknown
- 2004-01-07 NZ NZ540451A patent/NZ540451A/en not_active IP Right Cessation
- 2004-01-07 CN CNA2007101990278A patent/CN101259280A/zh active Pending
- 2004-01-07 PT PT80028921T patent/PT1917957T/pt unknown
- 2004-01-07 AT AT04700611T patent/ATE555779T1/de active
- 2004-01-07 ES ES16198417T patent/ES2735132T3/es not_active Expired - Lifetime
- 2004-01-07 DK DK08002892.1T patent/DK1917957T3/en active
- 2004-01-07 EP EP16198417.4A patent/EP3187177B1/en not_active Expired - Lifetime
- 2004-01-07 DK DK04700611.9T patent/DK1581193T3/da active
- 2004-01-07 EP EP14165593.6A patent/EP2799064B1/en not_active Expired - Lifetime
- 2004-01-07 TR TR2019/08857T patent/TR201908857T4/tr unknown
- 2004-01-07 EP EP04700611A patent/EP1581193B1/en not_active Expired - Lifetime
- 2004-01-07 HU HUE17188114 patent/HUE044694T2/hu unknown
- 2004-01-07 EP EP17188114.7A patent/EP3305284B1/en not_active Expired - Lifetime
- 2004-01-07 AU AU2004204744A patent/AU2004204744B2/en not_active Expired
- 2004-01-07 DK DK16198417.4T patent/DK3187177T3/da active
- 2004-01-07 CA CA002512315A patent/CA2512315C/en not_active Expired - Lifetime
- 2004-01-07 BR BR0406692-8A patent/BRPI0406692A/pt not_active Application Discontinuation
- 2004-01-07 WO PCT/US2004/000351 patent/WO2004062649A2/en active Application Filing
- 2004-01-07 PT PT17188114T patent/PT3305284T/pt unknown
- 2004-01-07 EP EP19174341.8A patent/EP3563839A1/en not_active Withdrawn
- 2004-01-07 DK DK14165593.6T patent/DK2799064T3/en active
- 2004-01-07 SI SI200432470T patent/SI3187177T1/sl unknown
- 2004-01-07 BR BR122015016901A patent/BR122015016901B8/pt not_active IP Right Cessation
- 2004-01-07 ES ES14165593.6T patent/ES2661383T3/es not_active Expired - Lifetime
- 2004-01-07 HU HUE08002892A patent/HUE030319T2/en unknown
- 2004-01-07 PT PT16198417T patent/PT3187177T/pt unknown
- 2004-01-07 JP JP2005507695A patent/JP4223040B2/ja not_active Expired - Lifetime
- 2004-01-07 SI SI200432427T patent/SI2799064T1/en unknown
- 2004-01-07 TR TR2018/02793T patent/TR201802793T4/tr unknown
-
2006
- 2006-04-04 HK HK06104158.4A patent/HK1084021A1/xx not_active IP Right Cessation
-
2012
- 2012-11-02 FR FR12C0067C patent/FR12C0067I1/fr active Active
-
2017
- 2017-01-17 CY CY20171100057T patent/CY1118431T1/el unknown
-
2018
- 2018-02-28 CY CY20181100250T patent/CY1120147T1/el unknown
-
2019
- 2019-06-13 CY CY20191100615T patent/CY1121731T1/el unknown
- 2019-08-13 CY CY20191100865T patent/CY1121912T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121731T1 (el) | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα | |
TW200621263A (en) | Ocular implant made by a double extrusion process | |
WO2006002366A3 (en) | Biodegradable ocular devices, methods and systems | |
ATE404140T1 (de) | Vorrichtung zur intraokularen wirkstoffverabreichung | |
DE60219607D1 (de) | Flexible mikrochip-vorrichtungen zur ophthalmologischen und anderen applikation | |
EP4292573A3 (en) | Apparatus for creating ocular surgical and relaxing incisions | |
WO2004050140A3 (en) | Medical devices for delivery of therapeutic agents | |
MX366832B (es) | Composiciones de farmaco de liberacion sostenida convenientemente implantables. | |
WO2010019507A3 (en) | Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues | |
AU3056702A (en) | Methods and compositions for treatment of ocular neovascularization and neural injury | |
WO2007076508A3 (en) | Implantable graft material | |
DK1779877T3 (da) | Bæremateriale for medicinske implantater | |
ATE446784T1 (de) | Konfiguration implantierter vorrichtungen | |
Service et al. | Alternative placement of the floating mass transducer in implanting the MED-EL Vibrant Soundbridge | |
AU2021903621A0 (en) | An implant and surgical procedures for the implanting thereof | |
KR20200121564A (ko) | 생체 삽입용 부재 | |
DE60017933D1 (de) | Element zur implantation in körpergewebe und gerät zu dessen herstellung | |
EP1547618A4 (en) | DRUG AGAINST HEARING TROUBLESHOOTING |